AtonRa Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,505
| Closed | -$472K | – | 131 |
|
|
2022
Q1 | $472K | Sell |
11,505
-2,473
| -18% | -$101K | 0.26% | 106 |
|
|
2021
Q4 | $608K | Sell |
13,978
-541
| -4% | -$23.5K | 0.21% | 107 |
|
|
2021
Q3 | $727K | Buy |
14,519
+405
| +3% | +$20.3K | 0.24% | 109 |
|
|
2021
Q2 | $889K | Sell |
14,114
-1,361
| -9% | -$85.7K | 0.33% | 103 |
|
|
2021
Q1 | $1.44M | Buy |
15,475
+3,355
| +28% | +$312K | 0.64% | 62 |
|
|
2020
Q4 | $1.09M | Buy |
+12,120
| New | +$1.09M | 0.53% | 61 |
|